Atlas Trials

Hepatic Impairment and Renal Impairment Study of SIM0417 Combined With Ritonavir

Clinical trial NCT05731804 · UNKNOWN

Trial details

NCT number
NCT05731804
Sponsor
Jiangsu Simcere Pharmaceutical Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Renal ImpairmentHepatic Impairment
Start date
2023-03-01
Primary completion
2023-12-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.